Nanjing Vcare Honored as "Best Customer Satisfaction CRO Enterprise"

2025-08-04

　　On August 1, the 7th CMC-CHINA Expo grandly commenced at the Suzhou International Expo Center. During the event, the"2025 China Pharmaceutical CRO CDMO Enterprise FNS101"list, co-initiated by the China Pharmaceutical Industry Expo and Pharm Cube, was unveiled. Nanjing Vcare Pharmatech Co., Ltd.(Nanjing Vcare) was honored with the title of "Best Customer Satisfaction CRO Enterprise" for its integrated drug lifecycle R&D and production services, exceptional project management, robust technical capabilities, and outstanding customer service advantages.

 

　　The"FNS101 Future New Species Top 100 Awards"– specifically the "China Pharmaceutical CRO CDMO Enterprise FNS101"– underwent rigorous evaluation by the FNS (Future New Species) expert panel to recognize comprehensive leaders in pharmaceutical outsourcing services. Nanjing Vcare's inclusion in this list signifies authoritative industry recognition of the company's core competitiveness in continuous innovation, technological expertise, and professional services.

　　Looking ahead, Nanjing Vcare will continue to deepen its capabilities in full-industry-chain drug R&D and lifecycle production services. The company remains committed to becoming a key enabler in China's pharmaceutical innovation ecosystem, assisting clients in enhancing R&D efficiency, accelerating drug commercialization, and contributing greater strength to the advancement of the pharmaceutical industry.

Prev

Nanjing Vcare's Production Subsidiary Tianshu Pharmaceutical Selected as 2025 Hubei Technology Innovation "New Species" Gazelle Enterprise

Next

Nanjing Vcare's Production Subsidiary Tianshu Pharmaceutical Obtains Japan's AFM Certification